Search for Clinical Trials
Patients with medical conditions requiring allogeneic hematopoietic cell transplantation (allo-HCT) are at risk of developing a condition called…
Seamless Phase II-Phase III Randomized Clinical Trial to Identify and Confirm the Most Promising Novel Intervention to Alleviate Morbidity and…
A Multi-Center, Phase II Trial of HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide
This…
Cell Therapy for High Risk T-cell Malignancies using CD7-Specific CAR Expressed on Non-Edited T cells (CRIMSON-NE)
Patients eligible for this study…
In this study, investigators attach the CD7 chimeric receptor with CD28 added to it to T cells that have had CD7 removed from their surface.
This is a Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2 or 3 prior…
This study is for patients who have lymphoma or leukemia that has come back or has not gone away after treatment.
This research study combines antibodies and T cells to fight a type of blood cancer called T-cell leukemia or lymphoma (lymph gland cancer).
The purpose of this study is to determine the safety and efficacy of KTE-C19 in relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL) in…
The purpose of this study is to see whether this therapy might help people with lymphoma or leukemia after a stem cell transplantation from a donor.
